PG2 Mrv0541 02231215562D 29 29 0 0 0 0 999 V2000 -3.5770 -0.5674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7923 -0.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6208 0.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8362 0.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2231 0.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4385 0.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2670 1.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5177 1.5143 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.7726 2.2989 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.5976 2.2989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8525 1.5143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1851 1.0293 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.1851 0.2043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4706 -0.2082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4706 -1.0332 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.1851 -1.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8996 -1.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6140 -1.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3285 -1.0332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.0430 -1.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7485 -1.3744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1901 -0.0154 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2877 2.9663 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.6372 1.2593 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.2438 -1.4457 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1048 1.9272 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.1959 2.2075 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.6648 0.7642 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.9763 -0.7412 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 21 1 0 0 0 0 1 22 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 6 7 1 0 0 0 0 8 7 1 1 0 0 0 8 9 1 0 0 0 0 8 12 1 0 0 0 0 8 26 1 6 0 0 0 9 10 1 0 0 0 0 9 23 1 1 0 0 0 9 27 1 6 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 11 24 2 0 0 0 0 12 13 1 6 0 0 0 12 28 1 1 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 15 25 1 1 0 0 0 15 29 1 1 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 1 0 0 0 0 M END > DB02056 > drugbank > [H][C@](O)(CCCCC)\C=C\[C@@]1([H])C(=O)C[C@]([H])(O)[C@]1([H])C\C=C/CCCC(O)=O > InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-/m0/s1 > BHMBVRSPMRCCGG-OUTUXVNYSA-N > C20H32O5 > 352.4651 > 352.224974134 > 5 > 57 > -0.9974680869950127 > 40.78026836323468 > 1 > 3 > 0 > 1 > (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoic acid > 3.12 > 3.2252701369999994 > -3.61 > 0 > -1 > 1 > -1 > 14.677904116939441 > 4.404553500058355 > -1.597397911002534 > 94.83 > 99.43509999999998 > 12 > 1 > 8.60e-02 g/l > tetrahydrofolic acid > 0 > DB02056 > EXPT02562; DB08863 > investigational > Prostaglandin D2 > (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate; 11-Dehydroprostaglandin F2-alpha; PGD2 $$$$